With one in eight American adults turning to GLP-1s for weight loss, eating habits and grocery shopping patterns are changing ...

The U.S. Food and Drug Administration (FDA) recently approved Eli Lilly and Company’s oral GLP-1 receptor agonist, Foundayo (orforglipron), ...

Oral weight-loss medications could widen demand, but the bigger issue is whether coverage is becoming a must-have benefit or ...

GLP-1 drugs such as Ozempic and Mounjaro are a revolution, not a trend. These weight loss drugs are one of the hottest markets in healthcare, and there’s been a dramatic surge in the number of ...

A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight ...

The UC Davis Innovation Institute for Food and Health recently hosted scientists, physicians and industry experts to discuss how drugs based on GLP-1 are transforming treatment for obesity, diabetes ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

New research highlights how GLP-1 receptor agonists influence gut bacteria, offering insights into their broader metabolic and anti-inflammatory benefits. Study: Effects of GLP-1 Analogues and ...

Lifestyle still essential: Experts stress gradual, enjoyable exercise and balanced nutrition as key to lasting weight loss, ...

This is read by an automated voice. Please report any issues or inconsistencies here. GLP-1 medications shift how your body handles digestion, often leading to side effects like bloating or ...

Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the treatment of type 2 diabetes and obesity. However, for many users, the benefits of weight loss and blood sugar management come ...